カテゴリー：世界, LP Information

医薬品連続生産の世界市場2025-2031

【英語タイトル】Global Pharmaceutical Continuous Manufacturing Market Growth (Status and Outlook) 2025-2031
	・商品コード：WR-A45778 ・発行会社（調査会社）：LP Information ・発行日：2025年8月・ページ数：約110 ・レポート言語：英語・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日）・調査対象地域：グローバル・産業分野：製薬

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,660 ⇒換算￥527,040	見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）	USD5,490 ⇒換算￥790,560	見積依頼/購入/質問フォーム
Corporate License（法人閲覧用）	USD7,320 ⇒換算￥1,054,080	見積依頼/購入/質問フォーム

※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）

❖ レポートの概要 ❖

本調査によると、世界の医薬品連続生産（Pharmaceutical Continuous Manufacturing）市場規模は2031年に28億5,000万米ドルに達すると予測されている。連続生産技術は、有効成分を自動化されたコンパクトで密閉されたユニット内で製造し、従来のバッチ生産で順次行われていた工程を連続的に統合する方式である。これにより人手介入が減少し、生産能力の継続的利用、変動の抑制、収率向上、運用・設備コスト削減といった利点が得られるため、採用が急速に進んでいる。

世界の医薬品市場は2022年に1兆4,750億ドル規模で、今後6年間は年平均5％の成長が見込まれる。内訳は化学薬品とバイオ医薬品で、2022年時点でバイオ医薬品市場は3,810億ドル、化学薬品市場は2018年の1兆50億ドルから1兆940億ドルに拡大している。市場成長の背景には、医療需要の増加、技術進歩、慢性疾患の拡大、民間および政府の製造開発支援資金、研究開発活動の増加がある。一方で、厳格な規制、高額な研究開発費、特許切れといった課題も存在し、企業は競争力を維持するために継続的な革新が求められている。さらにCOVID-19はワクチン開発やサプライチェーンの重要性を浮き彫りにし、製薬企業には迅速かつ柔軟な対応力が必要とされている。

LP Informationの最新調査レポート「Pharmaceutical Continuous Manufacturing Industry Forecast」では、2024年の販売データを基に2025年から2031年の市場を地域別・分野別に分析し、製品セグメント、企業動向、収益、M&Aの最新事例を含む詳細な見通しを提供している。分析は数百件に及ぶ定性・定量データに基づき、タイプ別（原薬、バイオ医薬品、ドライパウダー）、用途別（製薬企業、受託製造会社）、地域別（米州、APAC、欧州、中東・アフリカ）に分けて成長機会を示している。

対象企業には、Siemens、Corning Life Sciences、GEA Group、S K Biotek、Scott Equipment Company、Korsch、Continuus Pharmaceuticals、Chemtrixなどが含まれ、それぞれの製品ポートフォリオ、地理的展開、市場ポジションが評価されている。こうした調査から、医薬品連続生産市場は技術革新と医薬品需要の拡大を背景に、今後も大きな成長が期待される分野であることが明らかになっている。

According to this study, the global Pharmaceutical Continuous Manufacturing market size will reach US$ 2850 million by 2031.

In pharmaceutical continuous manufacturing technology, active ingredients are produced in compact, closed units, leveraging automation. Hence, it requires fewer manual interventions. Production steps carried out sequentially in a classic batch process are combined in a continuous process. All these help to bring about continued utilization of production capacity. This in turn serves to reduce fluctuations in production, improve yields, and lower costs of operation and equipment. On account of such advantages, the method is seeing fast adoption.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)’ newest research report, the “Pharmaceutical Continuous Manufacturing Industry Forecast” looks at past sales and reviews total world Pharmaceutical Continuous Manufacturing sales in 2024, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Continuous Manufacturing sales for 2025 through 2031. With Pharmaceutical Continuous Manufacturing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Continuous Manufacturing industry.

This Insight Report provides a comprehensive analysis of the global Pharmaceutical Continuous Manufacturing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Pharmaceutical Continuous Manufacturing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceutical Continuous Manufacturing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Continuous Manufacturing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Continuous Manufacturing.

This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Continuous Manufacturing market by product type, application, key players and key regions and countries.

Segmentation by Type:
Active Pharmaceutical Ingredient
Biologics
Dry Powders

Segmentation by Application:
Pharmaceutical Companies
Contract Manufacturing Organization

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.

Siemens
Corning Life Sciences
GEA Group
S K Biotek
Scott Equipment Company
Korsch
Continuus Pharmaceuticals
Chemtrix

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pharmaceutical Continuous Manufacturing Market Size (2020-2031)
2.1.2 Pharmaceutical Continuous Manufacturing Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Pharmaceutical Continuous Manufacturing by Country/Region (2020, 2024 & 2031)
2.2 Pharmaceutical Continuous Manufacturing Segment by Type
2.2.1 Active Pharmaceutical Ingredient
2.2.2 Biologics
2.2.3 Dry Powders
2.3 Pharmaceutical Continuous Manufacturing Market Size by Type
2.3.1 Pharmaceutical Continuous Manufacturing Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Pharmaceutical Continuous Manufacturing Market Size Market Share by Type (2020-2025)
2.4 Pharmaceutical Continuous Manufacturing Segment by Application
2.4.1 Pharmaceutical Companies
2.4.2 Contract Manufacturing Organization
2.5 Pharmaceutical Continuous Manufacturing Market Size by Application
2.5.1 Pharmaceutical Continuous Manufacturing Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Pharmaceutical Continuous Manufacturing Market Size Market Share by Application (2020-2025)
3 Pharmaceutical Continuous Manufacturing Market Size by Player
3.1 Pharmaceutical Continuous Manufacturing Market Size Market Share by Player
3.1.1 Global Pharmaceutical Continuous Manufacturing Revenue by Player (2020-2025)
3.1.2 Global Pharmaceutical Continuous Manufacturing Revenue Market Share by Player (2020-2025)
3.2 Global Pharmaceutical Continuous Manufacturing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Pharmaceutical Continuous Manufacturing by Region
4.1 Pharmaceutical Continuous Manufacturing Market Size by Region (2020-2025)
4.2 Global Pharmaceutical Continuous Manufacturing Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pharmaceutical Continuous Manufacturing Market Size Growth (2020-2025)
4.4 APAC Pharmaceutical Continuous Manufacturing Market Size Growth (2020-2025)
4.5 Europe Pharmaceutical Continuous Manufacturing Market Size Growth (2020-2025)
4.6 Middle East & Africa Pharmaceutical Continuous Manufacturing Market Size Growth (2020-2025)
5 Americas
5.1 Americas Pharmaceutical Continuous Manufacturing Market Size by Country (2020-2025)
5.2 Americas Pharmaceutical Continuous Manufacturing Market Size by Type (2020-2025)
5.3 Americas Pharmaceutical Continuous Manufacturing Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical Continuous Manufacturing Market Size by Region (2020-2025)
6.2 APAC Pharmaceutical Continuous Manufacturing Market Size by Type (2020-2025)
6.3 APAC Pharmaceutical Continuous Manufacturing Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Pharmaceutical Continuous Manufacturing Market Size by Country (2020-2025)
7.2 Europe Pharmaceutical Continuous Manufacturing Market Size by Type (2020-2025)
7.3 Europe Pharmaceutical Continuous Manufacturing Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pharmaceutical Continuous Manufacturing by Region (2020-2025)
8.2 Middle East & Africa Pharmaceutical Continuous Manufacturing Market Size by Type (2020-2025)
8.3 Middle East & Africa Pharmaceutical Continuous Manufacturing Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Pharmaceutical Continuous Manufacturing Market Forecast
10.1 Global Pharmaceutical Continuous Manufacturing Forecast by Region (2026-2031)
10.1.1 Global Pharmaceutical Continuous Manufacturing Forecast by Region (2026-2031)
10.1.2 Americas Pharmaceutical Continuous Manufacturing Forecast
10.1.3 APAC Pharmaceutical Continuous Manufacturing Forecast
10.1.4 Europe Pharmaceutical Continuous Manufacturing Forecast
10.1.5 Middle East & Africa Pharmaceutical Continuous Manufacturing Forecast
10.2 Americas Pharmaceutical Continuous Manufacturing Forecast by Country (2026-2031)
10.2.1 United States Market Pharmaceutical Continuous Manufacturing Forecast
10.2.2 Canada Market Pharmaceutical Continuous Manufacturing Forecast
10.2.3 Mexico Market Pharmaceutical Continuous Manufacturing Forecast
10.2.4 Brazil Market Pharmaceutical Continuous Manufacturing Forecast
10.3 APAC Pharmaceutical Continuous Manufacturing Forecast by Region (2026-2031)
10.3.1 China Pharmaceutical Continuous Manufacturing Market Forecast
10.3.2 Japan Market Pharmaceutical Continuous Manufacturing Forecast
10.3.3 Korea Market Pharmaceutical Continuous Manufacturing Forecast
10.3.4 Southeast Asia Market Pharmaceutical Continuous Manufacturing Forecast
10.3.5 India Market Pharmaceutical Continuous Manufacturing Forecast
10.3.6 Australia Market Pharmaceutical Continuous Manufacturing Forecast
10.4 Europe Pharmaceutical Continuous Manufacturing Forecast by Country (2026-2031)
10.4.1 Germany Market Pharmaceutical Continuous Manufacturing Forecast
10.4.2 France Market Pharmaceutical Continuous Manufacturing Forecast
10.4.3 UK Market Pharmaceutical Continuous Manufacturing Forecast
10.4.4 Italy Market Pharmaceutical Continuous Manufacturing Forecast
10.4.5 Russia Market Pharmaceutical Continuous Manufacturing Forecast
10.5 Middle East & Africa Pharmaceutical Continuous Manufacturing Forecast by Region (2026-2031)
10.5.1 Egypt Market Pharmaceutical Continuous Manufacturing Forecast
10.5.2 South Africa Market Pharmaceutical Continuous Manufacturing Forecast
10.5.3 Israel Market Pharmaceutical Continuous Manufacturing Forecast
10.5.4 Turkey Market Pharmaceutical Continuous Manufacturing Forecast
10.6 Global Pharmaceutical Continuous Manufacturing Forecast by Type (2026-2031)
10.7 Global Pharmaceutical Continuous Manufacturing Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Pharmaceutical Continuous Manufacturing Forecast
11 Key Players Analysis
11.1 Siemens
11.1.1 Siemens Company Information
11.1.2 Siemens Pharmaceutical Continuous Manufacturing Product Offered
11.1.3 Siemens Pharmaceutical Continuous Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Siemens Main Business Overview
11.1.5 Siemens Latest Developments
11.2 Corning Life Sciences
11.2.1 Corning Life Sciences Company Information
11.2.2 Corning Life Sciences Pharmaceutical Continuous Manufacturing Product Offered
11.2.3 Corning Life Sciences Pharmaceutical Continuous Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Corning Life Sciences Main Business Overview
11.2.5 Corning Life Sciences Latest Developments
11.3 GEA Group
11.3.1 GEA Group Company Information
11.3.2 GEA Group Pharmaceutical Continuous Manufacturing Product Offered
11.3.3 GEA Group Pharmaceutical Continuous Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 GEA Group Main Business Overview
11.3.5 GEA Group Latest Developments
11.4 S K Biotek
11.4.1 S K Biotek Company Information
11.4.2 S K Biotek Pharmaceutical Continuous Manufacturing Product Offered
11.4.3 S K Biotek Pharmaceutical Continuous Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 S K Biotek Main Business Overview
11.4.5 S K Biotek Latest Developments
11.5 Scott Equipment Company
11.5.1 Scott Equipment Company Company Information
11.5.2 Scott Equipment Company Pharmaceutical Continuous Manufacturing Product Offered
11.5.3 Scott Equipment Company Pharmaceutical Continuous Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Scott Equipment Company Main Business Overview
11.5.5 Scott Equipment Company Latest Developments
11.6 Korsch
11.6.1 Korsch Company Information
11.6.2 Korsch Pharmaceutical Continuous Manufacturing Product Offered
11.6.3 Korsch Pharmaceutical Continuous Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Korsch Main Business Overview
11.6.5 Korsch Latest Developments
11.7 Continuus Pharmaceuticals
11.7.1 Continuus Pharmaceuticals Company Information
11.7.2 Continuus Pharmaceuticals Pharmaceutical Continuous Manufacturing Product Offered
11.7.3 Continuus Pharmaceuticals Pharmaceutical Continuous Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Continuus Pharmaceuticals Main Business Overview
11.7.5 Continuus Pharmaceuticals Latest Developments
11.8 Chemtrix
11.8.1 Chemtrix Company Information
11.8.2 Chemtrix Pharmaceutical Continuous Manufacturing Product Offered
11.8.3 Chemtrix Pharmaceutical Continuous Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Chemtrix Main Business Overview
11.8.5 Chemtrix Latest Developments
12 Research Findings and Conclusion

List of Tables
Table 1. Pharmaceutical Continuous Manufacturing Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Pharmaceutical Continuous Manufacturing Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Active Pharmaceutical Ingredient
Table 4. Major Players of Biologics
Table 5. Major Players of Dry Powders
Table 6. Pharmaceutical Continuous Manufacturing Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Pharmaceutical Continuous Manufacturing Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Pharmaceutical Continuous Manufacturing Market Size Market Share by Type (2020-2025)
Table 9. Pharmaceutical Continuous Manufacturing Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Pharmaceutical Continuous Manufacturing Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Pharmaceutical Continuous Manufacturing Market Size Market Share by Application (2020-2025)
Table 12. Global Pharmaceutical Continuous Manufacturing Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Pharmaceutical Continuous Manufacturing Revenue Market Share by Player (2020-2025)
Table 14. Pharmaceutical Continuous Manufacturing Key Players Head office and Products Offered
Table 15. Pharmaceutical Continuous Manufacturing Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Pharmaceutical Continuous Manufacturing Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Pharmaceutical Continuous Manufacturing Market Size Market Share by Region (2020-2025)
Table 20. Global Pharmaceutical Continuous Manufacturing Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Pharmaceutical Continuous Manufacturing Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Pharmaceutical Continuous Manufacturing Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Pharmaceutical Continuous Manufacturing Market Size Market Share by Country (2020-2025)
Table 24. Americas Pharmaceutical Continuous Manufacturing Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Pharmaceutical Continuous Manufacturing Market Size Market Share by Type (2020-2025)
Table 26. Americas Pharmaceutical Continuous Manufacturing Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Pharmaceutical Continuous Manufacturing Market Size Market Share by Application (2020-2025)
Table 28. APAC Pharmaceutical Continuous Manufacturing Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Pharmaceutical Continuous Manufacturing Market Size Market Share by Region (2020-2025)
Table 30. APAC Pharmaceutical Continuous Manufacturing Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Pharmaceutical Continuous Manufacturing Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Pharmaceutical Continuous Manufacturing Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Pharmaceutical Continuous Manufacturing Market Size Market Share by Country (2020-2025)
Table 34. Europe Pharmaceutical Continuous Manufacturing Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Pharmaceutical Continuous Manufacturing Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Pharmaceutical Continuous Manufacturing Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Pharmaceutical Continuous Manufacturing Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Pharmaceutical Continuous Manufacturing Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Pharmaceutical Continuous Manufacturing
Table 40. Key Market Challenges & Risks of Pharmaceutical Continuous Manufacturing
Table 41. Key Industry Trends of Pharmaceutical Continuous Manufacturing
Table 42. Global Pharmaceutical Continuous Manufacturing Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Pharmaceutical Continuous Manufacturing Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Pharmaceutical Continuous Manufacturing Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Pharmaceutical Continuous Manufacturing Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Siemens Details, Company Type, Pharmaceutical Continuous Manufacturing Area Served and Its Competitors
Table 47. Siemens Pharmaceutical Continuous Manufacturing Product Offered
Table 48. Siemens Pharmaceutical Continuous Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Siemens Main Business
Table 50. Siemens Latest Developments
Table 51. Corning Life Sciences Details, Company Type, Pharmaceutical Continuous Manufacturing Area Served and Its Competitors
Table 52. Corning Life Sciences Pharmaceutical Continuous Manufacturing Product Offered
Table 53. Corning Life Sciences Pharmaceutical Continuous Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Corning Life Sciences Main Business
Table 55. Corning Life Sciences Latest Developments
Table 56. GEA Group Details, Company Type, Pharmaceutical Continuous Manufacturing Area Served and Its Competitors
Table 57. GEA Group Pharmaceutical Continuous Manufacturing Product Offered
Table 58. GEA Group Pharmaceutical Continuous Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. GEA Group Main Business
Table 60. GEA Group Latest Developments
Table 61. S K Biotek Details, Company Type, Pharmaceutical Continuous Manufacturing Area Served and Its Competitors
Table 62. S K Biotek Pharmaceutical Continuous Manufacturing Product Offered
Table 63. S K Biotek Pharmaceutical Continuous Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. S K Biotek Main Business
Table 65. S K Biotek Latest Developments
Table 66. Scott Equipment Company Details, Company Type, Pharmaceutical Continuous Manufacturing Area Served and Its Competitors
Table 67. Scott Equipment Company Pharmaceutical Continuous Manufacturing Product Offered
Table 68. Scott Equipment Company Pharmaceutical Continuous Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Scott Equipment Company Main Business
Table 70. Scott Equipment Company Latest Developments
Table 71. Korsch Details, Company Type, Pharmaceutical Continuous Manufacturing Area Served and Its Competitors
Table 72. Korsch Pharmaceutical Continuous Manufacturing Product Offered
Table 73. Korsch Pharmaceutical Continuous Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Korsch Main Business
Table 75. Korsch Latest Developments
Table 76. Continuus Pharmaceuticals Details, Company Type, Pharmaceutical Continuous Manufacturing Area Served and Its Competitors
Table 77. Continuus Pharmaceuticals Pharmaceutical Continuous Manufacturing Product Offered
Table 78. Continuus Pharmaceuticals Pharmaceutical Continuous Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Continuus Pharmaceuticals Main Business
Table 80. Continuus Pharmaceuticals Latest Developments
Table 81. Chemtrix Details, Company Type, Pharmaceutical Continuous Manufacturing Area Served and Its Competitors
Table 82. Chemtrix Pharmaceutical Continuous Manufacturing Product Offered
Table 83. Chemtrix Pharmaceutical Continuous Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Chemtrix Main Business
Table 85. Chemtrix Latest Developments

★調査レポート[医薬品連続生産の世界市場2025-2031] (コード：WR-A45778)販売に関する免責事項を必ずご確認ください。

★調査レポート[医薬品連続生産の世界市場2025-2031]についてメールでお問い合わせ

世界の市場調査レポート

医薬品連続生産の世界市場2025-2031

市場調査レポート・産業資料総合販売サイト MarketReport.jp

市場調査レポート・産業資料 総合販売サイト MarketReport.jp

市場調査レポート・産業資料総合販売サイト MarketReport.jp